Bio-Rad Laboratories stock draws attention after trend movement. Explore drivers, sector position, and healthcare technology ...
First-year students enrolled in principles of biology at Commonwealth University-Lock Haven recently participated in a ...
Hosted on MSN
Citigroup downgrades Bio-Rad Laboratories (BIO)
Fintel reports that on April 7, 2026, Citigroup downgraded their outlook for Bio-Rad Laboratories (NYSE:BIO) from Buy to Neutral. Analyst Price Forecast Suggests 22.54% Upside As of March 27, 2026, ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Digital PCR (dPCR) is the third generation of PCR technology, after conventional PCR and real-time quantitative PCR. It offers significant benefits over these other methods, making it ideal for a wide ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Bio-Rad develops products and solutions for the life sciences research and clinical diagnostic markets and enjoys niche market leadership in diagnostic quality controls, antigens, and digital ...
Bio-Rad Laboratories shares fell as the company faces margin pressure related to declining academic research funding. The stock slipped 10.6% to $261.43 Friday. Shares are down 14% over the past 12 ...
Chief Executive Officer — Norman Schwartz President and Chief Operating Officer — Jonathan DiVincenzo Executive Vice President and Chief Financial Officer — Roop Lakkaraju Yong Chung: Good afternoon, ...
The market didn't react positively to the diagnostics specialist's third-quarter earnings report. It beat on both the top and bottom lines, but growth rates were low. Bio-Rad's Q3 saw the company book ...
Bio-Rad Laboratories, Inc. (NYSE:BIO) ranks among the best medical stocks to buy according to analysts. On July 31, Bio-Rad Laboratories, Inc. (NYSE:BIO) posted second-quarter earnings that far ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results